Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome

Clinical and Experimental Rheumatology

Volumn 33, Issue 4, 2015, Pages 503-508

  Hernández Molina, Gabriela ^a   García Trejo, Liana P ^a   Uribe, Norma ^a   Cabral, Antonio R ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Antiphospholipid syndrome; Lupus nephropathy; Thrombotic microangiopathy

Indexed keywords

ANTIHYPERTENSIVE AGENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; BETA2 GLYCOPROTEIN 1;

ACUTE DISEASE; ADULT; AGE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIALYSIS; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THROMBOTIC THROMBOCYTOPENIC PURPURA; BIOPSY; BLOOD; COMPLICATION; DISEASE COURSE; IMMUNOLOGY; KIDNEY; KIDNEY FUNCTION TEST; LUPUS NEPHRITIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RENAL REPLACEMENT THERAPY; SEVERITY OF ILLNESS INDEX; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC MICROANGIOPATHIES; TISSUE SURVIVAL;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BIOPSY; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; THROMBOTIC MICROANGIOPATHIES; TISSUE SURVIVAL;

EID: 84939541475     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. KAMBHAM N: Introduction to thrombotic microangiopathies, In: Diagnostic Pathology: Kidney diseases. COLVIN RB, CHANG A, KAMBHAM N, CORNELL LD, FARRIS II AB, LIAPIS H, et al., (Eds.) Amirsys 2011: 3-64-92.
2. TEKTONIDOU MG, SOTSIOU F, NAKOPOULOU L, VLACHOYIANNOPOULOS PG, MOUTSOPOULOS HM: Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 2004; 50: 2569-79.
3. DAUGAS E, NOCHY D, HUONG DLT et al.: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002; 13: 42-52.
4. HU WX, LIU ZZ, CHEN HP, ZHANG HT, LI LS, LIU ZH: Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy. Lupus 2010; 19: 1591-8.
5. CHEUNSUCHON B, RUNGKAEW P, CHAWANASUNTORAPOJ R, PATTARAGARN A, PARICHATIKANOND P: Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Nephrology 2007; 12: 474-80.
6. JORDAN N, CHAIB A, SANGLE S et al.: Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients. Arthritis Care Res 2014; 66: 725-31.
7. NOCHY D, DAUGAS E, DROZ D et al.: The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999; 10: 507-18.
8. ERRE GL, BOSINCU L, FAEDDA R et al.: Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. Rheumatol Int 2014; 34: 535-41.
9. CERVERA R, TEKTONIDOU M, ESPINOSA G et al.: Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 2011; 20: 165-73.
10. MIYAKIS S, LOCKSHIN MD, ATSUMI T et al.: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
11. COHEN D, KOOPMANS M, KREMER HOVINGA IC et al.: Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum 2008; 58: 2460-9.
12. SONG D, WU LH, WANG FM et al.: The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 2013; 15: R12.
13. CHURG J BJ, GLASSOCK RJ: Renal Disease. Classification and Atlas of Glomerular Diseases. 1995.
14. CABIEDES J, CABRAL AR, ALARCóN-SEGOVIA D: Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
15. PENGO V, TRIPODI A, REBER G et al.: Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7: 1737-40.
16. MUBARAK M, NASRI H: What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions?. J Nephropathol 2014; 3: 4-8.
17. CANAUD G, BIENAIME F, TABARIN F et al.: Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med 2014; 371: 303-12.